IRVINE, Calif. (CBS.MW) -- Shares of Allergan jumped 6 percent Monday after the specialty pharmaceutical company announced it won a highly anticipated regulatory approval to market its Botox drug as a ...

Allergan Inc., the Irvine drug maker that’s Orange County’s second most valuable company after Broadcom Corp., got a bullish nod from Banc of America Securities, which started tracking the company.

LONDON (Reuters) - Britain's healthcare cost-effectiveness body NICE has changed its mind on Allergan's anti-wrinkle injection Botox and decided it is worth paying for on the state-funded health ...

Botox, used for smoothing out wrinkles, is the number one selling neurotoxin globally Allergan Aesthetics’ main product Botox received Food and Drug Administration approval for a new indication in ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. A federal jury July 18 said Revance Therapeutics' skin ...

BOSTON (CBS.MW) -- Medical products conglomerate Allergan reported a 13.7 percent jump Wednesday in pharmaceutical revenue for the second quarter, largely attributed to strong sales of its eye-care ...

NEW YORK, May 1 (Reuters) - Allergan Inc said first-quarter earnings fell by more than half as sales of its Botox anti-wrinkle drug and its medical devices fell, sending the company's shares down 6.2 ...

NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to ...

The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...

Valeant Pharmaceuticals announced yesterday that it plans to acquire Allergan with the help of investor Bill Ackerman. Should the plan succeed, the acquisition would create a dermatology and ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...